Australian Clinical Labs Limited (ACL.AX)
AUD 3.01
(-1.31%)
AUD 3.01
(-1.31%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 415.29 Million AUD | 2.23% |
| 2023 | 406.24 Million AUD | 2.72% |
| 2022 | 395.48 Million AUD | 0.69% |
| 2021 | 392.78 Million AUD | 32.22% |
| 2020 | 297.06 Million AUD | 135.41% |
| 2019 | 126.19 Million AUD | 11.08% |
| 2018 | 113.6 Million AUD | 6.4% |
| 2017 | 106.77 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 418.69 Million AUD | 3.06% |
| 2024 Q4 | 415.29 Million AUD | 0.0% |
| 2024 Q2 | 418.69 Million AUD | 0.0% |
| 2024 FY | 415.29 Million AUD | 2.23% |
| 2024 Q3 | 415.29 Million AUD | -0.81% |
| 2023 Q1 | 420.42 Million AUD | 6.3% |
| 2023 FY | 406.24 Million AUD | 2.72% |
| 2023 Q2 | 420.42 Million AUD | 0.0% |
| 2023 Q4 | 406.24 Million AUD | 0.0% |
| 2023 Q3 | 406.24 Million AUD | -3.37% |
| 2022 Q2 | 463.17 Million AUD | 0.0% |
| 2022 Q1 | 463.17 Million AUD | 17.92% |
| 2022 FY | 395.48 Million AUD | 0.69% |
| 2022 Q4 | 395.48 Million AUD | 0.0% |
| 2022 Q3 | 395.48 Million AUD | -14.61% |
| 2021 FY | 392.78 Million AUD | 32.22% |
| 2021 Q4 | 392.78 Million AUD | -2.34% |
| 2021 Q3 | 402.18 Million AUD | -14.44% |
| 2021 Q2 | 470.06 Million AUD | 30.72% |
| 2021 Q1 | 359.6 Million AUD | 21.05% |
| 2020 Q4 | 297.06 Million AUD | 0.0% |
| 2020 Q3 | 297.06 Million AUD | 0.0% |
| 2020 Q1 | - AUD | 0.0% |
| 2020 FY | 297.06 Million AUD | 135.41% |
| 2019 FY | 126.19 Million AUD | 11.08% |
| 2018 FY | 113.6 Million AUD | 6.4% |
| 2017 FY | 106.77 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| BCAL Diagnostics Limited | 3.67 Million AUD | -11193.842% |
| Genetic Signatures Limited | 6.18 Million AUD | -6615.637% |
| Genetic Technologies Limited | 4.35 Million AUD | -9433.629% |
| Healius Limited | 1.94 Billion AUD | 78.616% |
| Imagion Biosystems Limited | 8.37 Million AUD | -4859.15% |
| Integral Diagnostics Limited | 442.56 Million AUD | 6.163% |
| INOVIQ Ltd | 1.71 Million AUD | -24053.835% |
| Microba Life Sciences Limited | 16.82 Million AUD | -2368.423% |
| Monash IVF Group Limited | 261.81 Million AUD | -58.624% |
| Rhythm Biosciences Limited | 651.54 Thousand AUD | -63640.327% |
| Sonic Healthcare Limited | 6.75 Billion AUD | 93.849% |